186:
Pamonsinlapatham P, Hadj-Slimane R, Raynaud F, Bickle M, Corneloup C, Barthelaix A, Lepelletier Y, Mercier P, Schapira M, Samson J, Mathieu AL, Hugo N, Moncorgé O, Mikaelian I, Dufour S, Garbay C, Colas P.
180:
27:
320:
189:
A RasGAP SH3 peptide aptamer inhibits RasGAP-Aurora interaction and induces caspase-independent tumor cell death
167:
Cloning and characterization of human and mouse SNRK sucrose non-fermenting protein (SNF-1)-related kinases
116:
71:
107:
8:
38:
347:
342:
337:
301:
270:
239:
177:
Methods to identify anti-tumoral agents inhibiting RasGAP / Aurora Kinase interactions
304:
276:
262:
245:
291:
230:
218:
120:
192:
170:
331:
153:
124:
138:
98:
42:
82:
204:
31:
134:
62:
54:
165:
Kertesz N, Samson J, Debacker C, Wu H and
Labastie MC,
209:
175:
Garbay C, Gigoux V, Camonis J, L'Hoste S, Samson J,
74:, 2005-2006, Management consulting, Senior Associate
329:
297:
235:
198:
88:
57:, 2007-, Venture capital firm, Associate
16:
330:
65:, 2006, Venture capital firm, Analyst
28:University of Paris V: René Descartes
287:
258:
226:
214:
81:Further details can be found on my
13:
159:
14:
359:
135:Transatlantic cruise in Jan. 2007
33:), PhD in Pharmaceutical Sciences
268:This user can contribute with a
191:, PLoS One, 3(8):e2902, 2008.
1:
169:, Gene, 294(1-2):13-24, 2002
7:
210:The Boston Consulting Group
10:
364:
319:
298:
236:
217:
237:Cet utilisateur a pour
199:Selected external links
117:Boston Consulting Group
72:Boston Consulting Group
321:Search user languages
179:, Patent Application
108:metabolic engineering
89:My personal interests
299:Dieser Benutzer hat
17:A few words about me
39:Ecole Polytechnique
63:Sofinnova Partners
55:Seventure Partners
44:), Engineer degree
326:
325:
314:
313:
305:Deutschkenntnisse
284:
283:
255:
254:
240:langue maternelle
355:
310:
309:
288:
259:
251:
250:
227:
215:
131:Offshore Sailing
363:
362:
358:
357:
356:
354:
353:
352:
328:
327:
315:
285:
256:
219:Knowledge:Babel
201:
162:
160:My Publications
121:Venture Capital
91:
78:
19:
12:
11:
5:
361:
351:
350:
345:
340:
324:
323:
317:
316:
312:
311:
295:
286:
282:
281:
266:
257:
253:
252:
233:
225:
222:
221:
213:
212:
207:
200:
197:
196:
195:
184:
173:
161:
158:
157:
156:
147:
142:
128:
110:
101:
90:
87:
76:
75:
67:
66:
59:
58:
46:
45:
35:
34:
18:
15:
9:
6:
4:
3:
2:
360:
349:
346:
344:
341:
339:
336:
335:
333:
322:
318:
307:
306:
303:
296:
293:
290:
289:
279:
278:
273:
272:
267:
264:
261:
260:
248:
247:
242:
241:
234:
232:
229:
228:
224:
223:
220:
216:
211:
208:
206:
203:
202:
194:
193:PMID:18682833
190:
185:
182:
178:
174:
172:
171:PMID:12234663
168:
164:
163:
155:
154:half marathon
151:
148:
146:
143:
141:sailing boats
140:
136:
132:
129:
126:
125:Biotechnology
122:
118:
114:
111:
109:
105:
104:Biotechnology
102:
100:
96:
93:
92:
86:
84:
79:
73:
69:
68:
64:
61:
60:
56:
53:
52:
51:
50:
43:
41:, 1997-2000 (
40:
37:
36:
32:
30:, 2001-2005 (
29:
26:
25:
24:
23:
302:grundlegende
300:
275:
269:
244:
238:
188:
176:
166:
149:
145:Scuba diving
144:
130:
112:
103:
94:
80:
77:
48:
47:
21:
20:
271:near-native
332:Categories
205:Aptanomics
181:WO03087395
348:User de-1
343:User en-4
338:User fr-N
274:level of
22:Academics
246:français
139:Class 40
127:startups
113:Business
277:English
150:Running
99:aptamer
95:Biology
83:webpage
183:, 2003
70:The
49:Work
243:le
334::
294:-1
292:de
265:-4
263:en
231:fr
152::
137:,
133::
123:,
119:,
115::
106::
97::
85:.
308:.
280:.
249:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.